Skip to main content
CRL
NYSE Life Sciences

Bookings Hit Four-Year High as Biotech Demand Returns, Shares Surge 11%

Tom Rudovsky · Reported by Benzinga
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$259.99
Mkt Cap
$12.523B
52W Low
$144.26
52W High
$267.99
52W Position info
80% above low
Off High info
3.0% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

CRL sits 80% above its 52-week low of $144.26.

Summary

Charles River's Q2 bookings jumped to $701 million, the highest in nearly four years, with a book-to-bill ratio of 1.19x — concrete evidence that biotech demand is rebounding. This follows the earlier Q2 beat and guidance raise reported today, but the bookings data and 11% stock surge to a new 52-week high add fresh conviction. The DSA backlog expanded to $1.97 billion, driven by IND-enabling studies and strong NHP demand, while RMS weakness from flat NIH budgets persists. The raised full-year guidance now calls for EPS of $11.15-$11.45 on revenue of $3.879-$3.920 billion, both above consensus.

At the time of this announcement, CRL was trading at $259.99 on NYSE in the Life Sciences sector, with a market capitalization of approximately $12.5B. The 52-week trading range was $144.26 to $267.99. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Benzinga.


Price Chart

Share this article

Copied!

CRL - Latest Insights

CRL
Nov 09, 2026, 6:10 AM EST
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $337.44
Real-time Price: $325.80 info
Change: -$11.64 (-3%) info
Market Cap: $15.714B info
CRL
Nov 04, 2026, 9:03 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $342.99
Real-time Price: $325.80 info
Change: -$17.19 (-5%) info
Market Cap: $15.714B info
CRL
Nov 04, 2026, 7:04 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $362.01
Real-time Price: $325.80 info
Change: -$36.21 (-10%) info
Market Cap: $15.714B info
CRL
Nov 04, 2026, 7:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $362.00
Real-time Price: $325.80 info
Change: -$36.20 (-10%) info
Market Cap: $15.714B info
CRL
Sep 24, 2026, 8:12 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $278.01
Real-time Price: $325.80 info
Change: +$47.79 (+17%) info
Market Cap: $15.714B info